Kyoto University

Running trials

• Active, not recruiting

  GOREISAN for Heart Failure (GOREISAN-HF) Trial

  NCT04691700· Phase 4· Source

• Recruiting

  Predicting BCG Response

  NCT04564781· Source

• Recruiting

  A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

  NCT03193515· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer

  NCT04724460· Phase 4· Source

• Completed

  iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

  NCT04744532· Phase 1/2· Source

• Completed

  Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

  NCT02761070· Phase 3· Source

Trial sites

• Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine1 trial
• Kyoto University2 trials
• Kyoto University Graduate School of Medicine3 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Type 2 diabetes82 works · 0 trials
• Gastric and esophageal cancer65 works · 0 trials
• Colorectal cancer56 works · 0 trials
• Rheumatoid arthritis48 works · 0 trials
• Chronic kidney disease45 works · 0 trials
• Atopic dermatitis (eczema)40 works · 0 trials
• Bladder cancer34 works · 2 trials
• Pancreatic cancer30 works · 0 trials
• COPD29 works · 0 trials
• Acute myeloid leukemia28 works · 0 trials
• Lupus (SLE)22 works · 0 trials
• ALS (motor neurone disease)21 works · 1 trials
• Autism21 works · 0 trials
• Idiopathic pulmonary fibrosis19 works · 0 trials
• Myelodysplastic syndromes18 works · 0 trials
• Acute lymphoblastic leukaemia18 works · 0 trials
• Macular degeneration17 works · 0 trials
• Metastatic breast cancer14 works · 0 trials
• Neuroblastoma11 works · 0 trials
• ANCA-associated vasculitis8 works · 0 trials
• Chronic myeloid leukaemia6 works · 0 trials
• Polycystic kidney disease5 works · 0 trials
• Retinitis pigmentosa4 works · 0 trials